{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-272368","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.470136+00:00","generated_at":"2026-05-16T23:01:27.902317+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia Q3 net income $856k vs loss $1.6M YoY; Zola YTD revenue up 26%","bullets":["Q3 total revenue $1.30M, down 15% YoY; loss from operations $1.15M.","Net income attributable to common $856k ($0.63 diluted EPS) vs loss $1.61M ($1.18 loss) in Q3 2024.","Zola coconut water YTD revenue up 26% YoY; gross margin >30% for 11th straight quarter.","Cash balance $1.12M at Sept 30, 2025; pending Roosevelt Resources combination delayed by federal shutdown.","Recognized $4.7M credit loss on Above Food note; holds 2.7M ABVE shares valued at $3.07M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-272368","json":"https://secwatch.observer/filing/0001193125-25-272368.json","markdown":"https://secwatch.observer/filing/0001193125-25-272368.md","text":"https://secwatch.observer/filing/0001193125-25-272368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/0001193125-25-272368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/rkda-20251107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:01:27.902317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}